Secretion of platelet-activating factor is mediated by MDR1 P- glycoprotein in cultured human mesangial cells

Journal of the American Society of Nephrology

Volumn 10, Issue 11, 1999, Pages 2306-2313

  Ernest, Sylvain ^a   Bello Reuss, Elsa ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CYCLOSPORIN A; DOXORUBICIN; GLYCOPROTEIN P; LIPID; MULTIDRUG RESISTANCE PROTEIN; PEPTIDE; STEROID; THROMBOCYTE ACTIVATING FACTOR; VALSPODAR; VERAPAMIL; VINBLASTINE; XENOBIOTIC AGENT;

ARTICLE; CANCER CELL CULTURE; CELL SECRETION; CELL TRANSPORT; CONTROLLED STUDY; HENLE LOOP; HUMAN; HUMAN CELL; KIDNEY COLLECTING TUBULE; KIDNEY PROXIMAL TUBULE; MESANGIUM CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

EID: 0032709624     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Bello-Reuss E, Ernest S: Expression and function of P-glycoprotein in human mesangial cells. Am J Physiol 267: C1351-C1358, 1994
2. Gottesman MM, Pastan I: Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62: 385-427, 1993
3. Chin JE, Soffir R, Noonan KE, Choi K, Roninson IB: Structure and expression of the human MDR (P-glycoprotein) gene family. Mol Cell Biol 9: 3808-3820, 1989
4. Buschman E, Gros P: The inability of mouse mdr2 gene to confer multidrug resistance is linked to reduced drug binding to the protein. Cancer Res 54: 4892-4898, 1994
5. Raymond M, Gros P, Whiteway M, Thomas DY: Functional complementation of yeast ste6 by a mammalian multidrug resistance mdr gene. Science 256: 232-234, 1992
6. Saeki T, Ueda K, Tanigawara Y, Hori R, Komano T: Human P-glycoprotein transports cyclosporin A and FK506. J Biol Chem 268: 6077-6080, 1993
7. Ueda, K, Okamura N, Hirai M, Tanigawara Y, Saeki T, Kioka N, Komano T, Hori R: Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. J Biol Chem 267: 24248-24252, 1992
8. Bello-Reuss E, Ives KL, Hellmich MR, Ernest S: Verapamil decreases efflux of aldosterone and rhodamine 123 (R123) from NCI-H295 cells [Abstract], Proceedings of the 33rd International Congress of the Physiological Sciences, 1997, P006.27
9. Smit JJM, Schinkel AH, Oude Elferink RPJ, Groen AK, Wagenaar E, van Deemter L, Mol CAAM, Ottenhoff R, van der Lugt NMT, van Roon MA, van der Valk MA, Offerhaus GJA, Berns AJM, Borst P: Homozygous disruption of the murine mdr2 P-Glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75: 451-462, 1993
10. De Vree JML, Jacquemin E, Sturm E, Cresteil D, Bosma PJ, Aten J, Deleuze J-F, Desrochers M, Burdelski M, Bernard O, Oude Elferink RPJ, Hadchouel M: Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci USA 95: 282-287, 1998
11. Bosch I, Dunussi-Joannopoulos K, Wu R-L, Furlong ST, Croop J: Phosphatidylcholine and phosphatidylethanolamine behave as substrates of human MDR1 P-glycoprotein. Biochemistry 36: 5685-5694, 1997
12. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC: Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 84: 7735-7738, 1987
13. Ernest S, Rajaraman S, Megyesi J, Bello-Reuss E: Expression of MDR1 (multidrug resistance) gene and its protein in normal human kidney. Nephron 77: 284-289, 1997
14. Ardaillou R, Ronco P, Rondeau E: Biology of renal cells in culture. In: The Kidney, 5th Ed., edited by Brenner BM, Philadelphia, Saunders, 1996, pp 99-192
15. Ernest S, Bello-Reuss B: P-glycoprotein functions and substrates: Possible roles for MDR1 gene in the kidney. Kidney Int 65: S11-S17, 1998
16. Schlondorff D, Goldwasser P, Neuwirth R, Satriano JA, Clay KL: Production of platelet-activating factor in glomeruli and cultured glomerular mesangial cells. Am J Physiol 250: F1123-F1127, 1986
17. Neuwirth R, Satriano JA, DeCandido S, Clay K, Schlondorff D: Angiotensin II causes formation of platelet activating factor in cultured rat mesangial cells. Circ Res 64: 1224-1229, 1989
18. Camussi G, Biancone L, Iorio EL, Silvestro L, Da Col R, Capasso C, Rossano F, Servillo L, Balestrieri C, Tufano MA: Porins and lipopolysaccharide stimulate platelet activating factor synthesis by human mesangial cells. Kidney Int 42: 1309-1318, 1992
19. Schlondorff D, Neuwirth R: Platelet-activating factor and the kidney. Am J Physiol 251: F1-F11, 1986
20. Wilson CB: Renal response to immunologic glomerular injury. In: The Kidney, 5th Ed., edited by Brenner BM, Philadelphia, Saunders, 1996, pp 1253-1391
21. Banks JB, Wykle RL, O'Flaherty JT, Lumb RH: Evidence for protein-catalyzed transfer of platelet-activating factor by macrophage cytosol. Biochim Biophys Acta 961: 48-52, 1988
22. Akiyama S-i, Fojo A, Hanover JA, Pastan I, Gottesman MM: Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somat Cell Mol Genet 11: 117-126, 1985
23. Altenberg GA, Vanoye CG, Horton JK, Reuss L: Unidirectional fluxes of rhodamine 123 in multidrug-resistant cells: Evidence against direct drug extrusion from the plasma membrane. Proc Natl Acad Sci USA 91: 4654-4657, 1994
24. Ernest S, Bello-Reuss E: Expression and function of P-glycoprotein in a mouse kidney cell line. Am J Physiol 269: C323-C333, 1995
25. Essodaigui M, Broxterman HJ, Garnier-Suillerot A: Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein. Biochemistry 37: 2243-2250, 1998
26. Dentan C, Tselepis AD, Chapman MJ, Ninio E: Pefabloc, 4-[2-aminoethyl] benzenesulfonyl fluoride, is a new, potent nontoxic and irreversible inhibitor of PAF-degrading acetylhydrolase. Biochem Biophys Acta 1299: 353-357, 1996
27. Rivoltini L, Colombo MP, Supino R, Ballinari D, Tsuruo T, Parmiani G: Modulation of multidrug resistance by verapamil or mdr1 anti-sense oligodeoxynucleotide does not change the high susceptibility to lymphokine-activated killers in mdr-resistant human carcinoma (LoVo) line. Int J Cancer 46: 727-732, 1990
28. Watson JV: Significance testing and fit criteria. In: Flow Cytomerry Data Analysis: Basic Concepts and Statistics, edited by Watson JV, New York. Cambridge University Press, 1992, pp 31-57
29. Wallestein S, Zucker CL, Fleiss JL: Some statistical methods useful in circulation research. Circ Res 47: 7-9, 1980
30. Van Helvoort A, Smith AJ, Sprong H, Fritzsche I, Schinkel AH, Borst P, van Meer G: MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell 87: 507-517, 1996
31. Hsieh K-H, Ng C-K: Increased plasma platelet-activating factor in children with acute asthmatic attacks and decreased in vivo and in vitro production of platelet-activating factor after immunotherapy. J Allergy Clin Immunol 91: 650-657, 1993
32. Bustos C, Gonzales-Cuadrado S, Ruiz-Ortega M, Gomez Guerrero C, Gonzalez E, Plaza JJ, Egido J: Cyclosporin A (CsA) modulates the glomerular production of inflammatory mediators and proteoglycans in experimental nephrosis. Clin Exp Immunol 102: 608-613, 1995